CHK
39
19
PLD
58
10
HBI
62
7
GME
75
-14
UPS
51
-2
VLO
45
6
CMG
70
-2
OI
39
-4
MCK
73
2
MDLZ
46
-4
FSLR
76
3
ABBV
64
4
AVY
77
2
IRM
71
-2
TSN
38
-2
CSX
39
-4
NVDA
60
-3
HPE
44
-2
KSS
47
-4
CAH
43
2
CHK
39
19
PLD
58
10
HBI
62
7
GME
75
-14
UPS
51
-2
VLO
45
6
CMG
70
-2
OI
39
-4
MCK
73
2
MDLZ
46
-4
FSLR
76
3
ABBV
64
4
AVY
77
2
IRM
71
-2
TSN
38
-2
CSX
39
-4
NVDA
60
-3
HPE
44
-2
KSS
47
-4
CAH
43
2
Financhill
Back

BioNTech SE Stock Predictions

Sell
22

BNTX
BioNTech SE

Last Price:
90.62
Seasonality Move:
35.2%

7 Day Trial

ALL ACCESS PASS

$ 7

BioNTech SE Stock Forecast

  • Over the next 52 weeks, BioNTech SE has on average historically risen by 58.6% based on the past 4 years of stock performance.
  • BioNTech SE has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
  • Is BioNTech SE Stock Undervalued?
    The current BioNTech SE [BNTX] share price is $90.61. The Score for BNTX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • BNTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will BioNTech SE Stock Go Up Next Year?

  • Over the next 52 weeks, BioNTech SE has on average historically risen by 58.6% based on the past 4 years of stock performance.

BioNTech SE Stock Rating

Sell
22
BioNTech SE (BNTX) is a Sell

Is BioNTech SE overpriced?

  • BioNTech SE has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%

BioNTech SE Stock Price History

Is BNTX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BNTX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Germany
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biontech.de

52-Week Data

52-Week High:
125.83
52-Week Low:
85.21

Prediction Charts

Market Cap:
21.84B
Price in USD:
90.61
Volume:
471.66K
Beta:
0.26

Technical Analysis

SMA50:
90.67
SMA100:
94.13
SMA200:
99.70
52-Wk Change:
-13.83%

Stock Predictions

  • Is BioNTech SE stock public?
    Yes, BioNTech SE is a publicly traded company.
  • What is the BioNTech SE stock quote today?
    The BioNTech SE stock price is 90.61 USD today.
  • How to buy BioNTech SE stock online?
    You can buy BioNTech SE shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-30 88.39 88.82 89.62 87.87
May-1 86.77 89.95 90.66 86.36
May-2 90.75 92.24 92.40 90.68
May-3 93.42 92.72 93.54 91.60
May-6 90.09 93.35 95.29 89.94
May-7 92.85 90.88 93.23 90.75
May-8 90.72 90.13 90.99 89.38
May-9 90.24 92.01 93.86 90.14
May-10 92.59 91.67 93.39 91.53
May-13 92.56 92.72 93.48 92.41
May-14 92.79 92.28 93.22 91.71
May-15 93.00 92.20 93.00 91.60
May-16 92.00 92.98 93.30 91.78
May-17 92.80 90.61 92.80 90.54

BioNTech SE Earnings

BioNTech SE Earnings Report: Per Share BioNTech SE Earnings Q1 Q2 Q3 and Q4 last year and next year.

BioNTech SE Forecast Revenue Growth

BioNTech SE Stock Analysis: Historical quarterly revenues per share for BioNTech SE and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.73 per share, a decrease next quarter of $0.76 per share, a decrease this year of $6.61 per share, and a decrease next year of $0.34 per share.

* BioNTech SE stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.